Identification of potent and selective RNA antagonists of the IFN-gamma-inducible CXCL10 chemokine.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Biochemistry

• Publication date

  2005-05-21

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI048145WPMID 15938634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients.

  2003cited by this paper
• The C-X-C chemokine IP-10 stimulates HIV-1 replication.

  2003cited by this paper
• CXCR3 and Heparin Binding Sites of the Chemokine IP-10 (CXCL10)*

  2003cited by this paper
• CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11

  2003cited by this paper
• Mfold web server for nucleic acid folding and hybridization prediction

  2003cited by this paper
• Absence of CCR8 Does Not Impair the Response to Ovalbumin-Induced Allergic Airway Disease 1

  2003cited by this paper
• Strategies for chemokine antagonists as therapeutics.

  2003cited by this paper
• Elevated Serum Levels of the CXCR3 Chemokine ITAC Are Associated With the Development of Transplant Coronary Artery Disease

  2003cited by this paper
• IFN-γ-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking1

  2002cited by this paper
• Donor T Cell Activation Initiates Small Bowel Allograft Rejection Through an IFN-γ-Inducible Protein-10-Dependent Mechanism1

  2002cited by this paper
• Aptamers and aptazymes: accelerating small molecule drug discovery.

  2002cited by this paper
• Differential Role of IFN-γ-Inducible Protein 10 kDa in a Cockroach Antigen-Induced Model of Allergic Airway Hyperreactivity: Systemic Versus Local Effects1

  2002cited by this paper
• Platelet Factor 4 Inhibits Proliferation and Cytokine Release of Activated Human T Cells1

  2002cited by this paper
• Generation of RNA aptamers to the G-protein-coupled receptor for neurotensin, NTS-1.

  2002cited by this paper
• Differential Expression of the IFN-γ-Inducible CXCR3-Binding Chemokines, IFN-Inducible Protein 10, Monokine Induced by IFN, and IFN-Inducible T Cell α Chemoattractant in Human Cardiac Allografts: Association with Cardiac Allograft Vasculopathy and Acute Rejection1

  2002cited by this paper
• The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions.

  2002cited by this paper
• Interaction of the CC-Chemokine RANTES with Glycosaminoglycans Activates a p44/p42 Mitogen-Activated Protein Kinase-Dependent Signaling Pathway and Enhances Human Immunodeficiency Virus Type 1 Infectivity

  2002cited by this paper
• Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival

  2002cited by this paper
• The Ligands of CXC Chemokine Receptor 3, I-TAC, Mig, and IP10, Are Natural Antagonists for CCR3*

  2001cited by this paper
• The generation and characterisation of antagonist RNA aptamers to MCP‐1

  2001cited by this paper
• Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor.

  2001cited by this paper
• Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation

  2001cited by this paper
• C-C Chemokine Receptor 4 Expression Defines a Major Subset of Circulating Nonintestinal Memory T Cells of Both Th1 and Th2 Potential

  2001cited by this paper
• Anti-L-Selectin Aptamers: Binding Characteristics, Pharmacokinetic Parameters, and Activity Against an Intravascular Target In Vivo

  2000cited by this paper
• Nucleic acid aptamers-from selection in vitro to applications in vivo.

  2000cited by this paper
• The Generation and Characterization of Antagonist RNA Aptamers to Human Oncostatin M*

  2000cited by this paper
• IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection.

  2000cited by this paper
• Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection

  2000cited by this paper
• Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.

  1999cited by this paper
• Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells.

  1999cited by this paper
• Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors.

  1999cited by this paper
• CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.

  1999cited by this paper
• The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions.

  1999cited by this paper
• 2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165)

  1998cited by this paper
• The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3.

  1998cited by this paper
• Chemokines--chemotactic cytokines that mediate inflammation.

  1998cited by this paper
• Lymphocyte‐specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization

  1998cited by this paper
• Glycosaminoglycans mediate cell surface oligomerization of chemokines.

  1997cited by this paper
• Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10.

  1996cited by this paper
• Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases

  1996cited by this paper
• A SELEX primer.

  1996cited by this paper
• Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis.

  1995cited by this paper
• The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation

  1995cited by this paper
• Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

  1995cited by this paper
• Diversity of oligonucleotide functions.

  1995cited by this paper
• Constitutive expression of interferon gamma-inducible protein 10 in lymphoid organs and inducible expression in T cells and thymocytes

  1994cited by this paper
• T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta.

  1993cited by this paper
• IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

  1993cited by this paper
• In vitro selection of RNA molecules that bind specific ligands

  1990cited by this paper
• Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

  1990cited by this paper
• Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques

  1988cited by this paper
• Biochemical characterization of a gamma interferon-inducible cytokine (IP-10)

  1987cited by this paper
• Genomic characterization of a gamma-interferon-inducible gene (IP-10) and identification of an interferon-inducible hypersensitive site

  1987cited by this paper
• γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins

  1985cited by this paper

• Aptamers: promising tool for disease diagnosis and treatment

  2025cites this paper
• Nucleic Acid and Nanomaterial Synergistic Amplification Enables Dual Targets of Ultrasensitive Fluorescence Quantification to Improve the Efficacy of Clinical Tuberculosis Diagnosis.

  2024cites this paper
• Tetrad metal ion mediated molecular switch aptamer sensor for fluorescence assay of plasma IP-10 in clinical tuberculosis

  2024cites this paper
• Aptamer-Based Immune Drug Systems (AptIDCs) Potentiating Cancer Immunotherapy

  2023cites this paper
• Aptamers for Targeted Therapy

  2021cites this paper
• Challenges of SELEX and Demerits of Aptamer-Based Methods

  2018cites this paper
• Advances in structure-switching aptasensing towards real time detection of cytokines

  2018cites this paper
• Functional Modulation of Activated Protein C using DNA-Aptamers

  2017cites this paper
• Aptamers Against Pro- and Anti-Inflammatory Cytokines: A Review

  2017cites this paper
• Aptamers Against Immunologic Targets: Diagnostic and Therapeutic Prospects

  2016cites this paper
• Desarrollo y caracterización de aptámeros de rna y dna frente a la proteína erbb3 binding protein-1 mediante procedimientos de selección y evolución in vitro

  2016cites this paper
• Cancer immunotherapy via nucleic acid aptamers.

  2015cites this paper
• Use of RNA aptamers for enhanced drug therapy and imaging

  2014influential citation
• Recent Developments in Affinity Chromatography by Panagiotis Spyropoulos April , 2014

  2014cites this paper
• The development of aptamer-based probes for the detection of TB antigens ESAT-6.CFP-10 potential TB diagnostic tools

  2013cites this paper
• Development of aptamer conjugates for targeted cancer therapy

  2012cites this paper
• Aptamer-Functionalized Nanomaterials for Cell Recognition

  2012cites this paper
• In vitro Selection of DNA Aptamers to Glioblastoma Multiforme.

  2011influential citation
• Charakterisierung von RNA-Aptameren mit Spezifität für den humanen Interleukin-6-Rezeptor

  2011cites this paper
• Aptamers as therapeutics in cardiovascular diseases.

  2011cites this paper
• Aptamers as therapeutics

  2010cites this paper
• Aptamers as candidate therapeutics for cardiovascular indications.

  2008cites this paper
• Aptamers in Immunotherapy

  2008cites this paper
• High sensitive, colorimetric, isothermal nucleic acids amplification: A versatile platform for protein biosensors

  2008cites this paper
• Characterisation of aptamers for therapeutic studies

  2007cites this paper
• Nucleic acid-based aptamers as promising therapeutics in neoplastic diseases.

  2007cites this paper
• Oxazolidinones as novel human CCR8 antagonists.

  2007cites this paper
• SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.

  2007cites this paper
• Survey of the year 2005 commercial optical biosensor literature

  2006cites this paper
• In vitro selection of RNA aptamers that block CCL1 chemokine function.

  2006cites this paper
• Aptamer therapeutics advance.

  2006cites this paper
• Aptamers—basic research, drug development, and clinical applications

  2005influential citation
• Survey of the year 2003 commercial optical biosensor literature

  2005cites this paper